Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kufner

Showing results (251-260 of 370) with videos related to

Pageof 37
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 23, 2015
Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trialsSalvatore Cassese, Sebastian Kufner, Erion Xhepa, et al.
JACC. Cardiovascular Interventions|March 28, 2016
Randomized Trial of Polymer-Free Sirolimus- and Probucol-Eluting Stents Versus Durable Polymer Zotarolimus-Eluting Stents: 5-Year Results of the ISAR-TEST-5 TrialSebastian Kufner, Jonas Sorges, Julinda Mehilli, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2016
Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registryJens Wiebe, Petra Hoppmann, Sebastian Kufner, et al.
Journal of Clinical Medicine|October 16, 2024
A Prospective, Randomized Trial of Bioresorbable Polymer Drug-Eluting Stents versus Fully Bioresorbable Scaffolds in Patients Undergoing Coronary StentingJens Wiebe, Robert A Byrne, Christian Bradaric, et al.
Brain, Behavior, & Immunity - Health|November 30, 2023
Depressive symptoms and anti-N-methyl-D-aspartate-receptor GluN1 antibody seropositivity in the PROSpective cohort with incident strokePia S Sperber, Pimrapat Gebert, Leonie H A Broersen, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 6, 2025
Long term follow up of patients treated with a polymer coated non drug-eluting stent in the COBRA-REDUCE trialJola Bresha, Karsten P Hug, Robert A Byrne, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 5, 2013
One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trialStefanie Schulz, Adnan Kastrati, Miroslaw Ferenc, et al.
Journal of the American Heart Association|July 27, 2017
ISAR-PEBIS (Paclitaxel-Eluting Balloon Versus Conventional Balloon Angioplasty for In-Stent Restenosis of Superficial Femoral Artery): A Randomized TrialIlka Ott, Salvatore Cassese, Philipp Groha, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 4, 2015
Increased bleeding risk during percutaneous coronary interventions by arterial hypertensionGjin Ndrepepa, Philipp Groha, Anna L Lahmann, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 14, 2023
Derivation and validation of the ISAR score to predict the risk of repeat percutaneous coronary intervention for recurrent drug-eluting stent restenosisJ J Coughlan, Alp Aytekin, Shqipdona Lahu, et al.
Pageof 37

Showing results (251-260 of 370) with videos related to

Sort By:
Pageof 37
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 23, 2015
Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trialsSalvatore Cassese, Sebastian Kufner, Erion Xhepa, et al.
JACC. Cardiovascular Interventions|March 28, 2016
Randomized Trial of Polymer-Free Sirolimus- and Probucol-Eluting Stents Versus Durable Polymer Zotarolimus-Eluting Stents: 5-Year Results of the ISAR-TEST-5 TrialSebastian Kufner, Jonas Sorges, Julinda Mehilli, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2016
Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registryJens Wiebe, Petra Hoppmann, Sebastian Kufner, et al.
Journal of Clinical Medicine|October 16, 2024
A Prospective, Randomized Trial of Bioresorbable Polymer Drug-Eluting Stents versus Fully Bioresorbable Scaffolds in Patients Undergoing Coronary StentingJens Wiebe, Robert A Byrne, Christian Bradaric, et al.
Brain, Behavior, & Immunity - Health|November 30, 2023
Depressive symptoms and anti-N-methyl-D-aspartate-receptor GluN1 antibody seropositivity in the PROSpective cohort with incident strokePia S Sperber, Pimrapat Gebert, Leonie H A Broersen, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 6, 2025
Long term follow up of patients treated with a polymer coated non drug-eluting stent in the COBRA-REDUCE trialJola Bresha, Karsten P Hug, Robert A Byrne, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 5, 2013
One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trialStefanie Schulz, Adnan Kastrati, Miroslaw Ferenc, et al.
Journal of the American Heart Association|July 27, 2017
ISAR-PEBIS (Paclitaxel-Eluting Balloon Versus Conventional Balloon Angioplasty for In-Stent Restenosis of Superficial Femoral Artery): A Randomized TrialIlka Ott, Salvatore Cassese, Philipp Groha, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 4, 2015
Increased bleeding risk during percutaneous coronary interventions by arterial hypertensionGjin Ndrepepa, Philipp Groha, Anna L Lahmann, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 14, 2023
Derivation and validation of the ISAR score to predict the risk of repeat percutaneous coronary intervention for recurrent drug-eluting stent restenosisJ J Coughlan, Alp Aytekin, Shqipdona Lahu, et al.
Pageof 37